Moreover, substantial evidence has shown that PDE4D inhibitors are able to rescue compromised LTP in different models of pathological conditions, including AD (Bliss and Collingridge, 1993; Ricciarelli and Fedele, 2015). The gene discussed is PDE4D; the disease is Alzheimer disease.